# Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer

> **NCT02655913** · PHASE1,PHASE2 · COMPLETED · sponsor: **Clifford Hospital, Guangzhou, China** · enrollment: 97 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer
- Recurrent Non-small Cell Lung Cancer

## Interventions

- **DRUG:** vitamin C
- **DEVICE:** Modulated Electro-Hyperthermia (mEHT)
- **OTHER:** Supportive care

## Key facts

- **NCT ID:** NCT02655913
- **Lead sponsor:** Clifford Hospital, Guangzhou, China
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-08
- **Final completion:** 2018-08
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2018-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655913, "Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02655913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
